Articular Cartilage Regeneration with Stem Cells by Khay-Yong Saw et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Articular Cartilage Regeneration with Stem Cells 
Khay-Yong Saw1, Adam Anz2, Kathryne Stabile2, Caroline SY Jee3,  
Shahrin Merican1, Yong-Guan Tay1 and Kunaseegaran Ragavanaidu4 
1Kuala Lumpur Sports Medicine Centre, 
2Wake Forest University Baptist Medical Center, 
 3The University of Nottingham Malaysia Campus; 




Cartilage defects continue to be a clinical challenge as regards to articular cartilage 
regeneration. The structure and function of articular cartilage leads to non-healing lesions 
after injury occurs. Well-established arthroscopic methods utilize controlled healing with 
marrow stimulation or transferring of non-injured cartilage to areas of injury. These include: 
microfracture, chondral drilling, osteochondral autograft transfer system, ostechondral 
allograft transplant, and autologous chondrocyte implantation. However, more often than 
not the treatments result in the formation of fibrocartilage and similar results within all 
methods with no clear superior modality (Jakobsen et al, 2005; Lubowitz et al, 2007; 
Magnussen et al, 2008; Nakamura et al, 2009). Recent study has investigated synthetic and 
biologic adjuncts to current methodology, including the use of: hyaluronic acid (HA), 
platelet rich plasma, mesenchymal stem cells (MSC) and peripheral blood progenitor cells 
(PBPC). Cell therapy has produced exciting results in animal models and has been shown to 
regenerate hyaline cartilage clinically in the knee joint. Our current method utilizes 
arthroscopic subchondral drilling of cartilage lesions in combination with a postoperative 
adjunct treatment involving: stimulation of the release of PBPC with filgrastim, harvest of 
PBPC with apheresis, and postoperative intraarticular injection of PBPC in combination 
with HA. Our early results lead us to the conclusion that cell therapy will have an integral 
part in the future treatment of cartilage damage as well as other potential orthopedic, 
surgical, and medical applications.  
2. Anatomy of articular cartilage 
Understanding the form and function of articular cartilage is the cornerstone to developing 
successful treatments for articular cartilage damage. Articular cartilage is a tissue that bears 
load and forms the articulating surfaces of diarthrodial joints. Articular cartilage dissipates 
loads, has low friction, provides lubrication, and can last up to 8 decades. 
Articular cartilage is predominately composed of extracellular matrix (ECM) with a sparse 
population of chondrocytes that help to maintain the ECM. The major components of the 
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ECM are water, collagen, and proteoglycans. These combine with the chondrocytes to form 
the complex structure of articular cartilage which varies throughout its depth. The structure 
of articular cartilage is typically divided into 4 zones (superficial, middle, deep, and zone of 
calcified cartilage). The superficial zone or tangential zone is adjacent to the joint cavity and 
forms a gliding surface. The superficial zone is characterized by thin collagen fibrils that are 
aligned parallel with the articular surface. This zone also has disk shaped chondrocytes, low 
proteoglycan content, with high collagen and water contents. The middle (transitional) zone 
is characterized by large diameter collagen fibers which are oriented obliquely, round 
chondrocytes, and an increased proteoglycan content. The deep (radial) zone has the highest 
proteoglycan content with collagen fibers oriented perpendicular to the joint surface. The 
chondrocytes in the deep zone are round and organized into columns. The deepest layer is 
the zone of calcified cartilage and separates the hyaline cartilage from the subchondral bone. 
This zone is characterized by collagen fibrils that are radially aligned with round 
chondrocytes that are buried in calcified matrix. This zone has a low concentration of 
proteoglycans and a high concentration of calcium salts (Fig 1). 
 
 
Fig. 1. This figure illustrates the zones of hyaline cartilage: superficial, middle, deep, and 
zone of calcified cartilage. Lacunae are present in hyaline cartilage and typically contains 1-2 
chondrocytes. There is a periphery of increased proteoglycan content around each 
chondrocyte and lacuna. 
Articular cartilage is avascular and obtains its nutrition from the diffusion of synovial fluid 
through the ECM and from underlying bone. Chondrocytes produce ECM components in 
response to chemical (growth factor and cytokines) and physical (mechanical load, 
hydrostatic pressure) stimuli. The ECM is composed primarily of water 65-80%, collagen 
(type II) 10-20%, and aggrecan 4-7%. Other components of the ECM make up less than 5% of 
articular cartilage. These include proteoglycans, biglycan, decorin, fibromodulin, various 
collagen types (V, VI, IX, X, XI), link protein, hyaluronate, fibronectin, and lipids. The role of 
each of these molecules is not fully understood. Collagen functions to provide shear and 
tensile strength to the cartilage. Proteoglycans are produced and secreted by the 
chondrocytes. Proteoglycans are tangled in between collagen fibers creating an ECM that 
inhibits the movement of water and provides compression strength of cartilage. Aggrecan 
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molecules for example bind with hyaluronic acid to create macromolecules (proteoglycan 
aggregate). These macromolecules are effectively immobilized in the collagen ECM. There 
tends to be a higher concentration of proteoglycans in the ECM closest to the chondrocytes. 
Proteoglycans are made up of repeating dissacharaide subunits called glycosaminoglycans 
(GAG). There are 3 types of GAGs found in cartilage 1. chondroitin sulfate, 2. keratin 
sulfate, and 3. dermatan sulfate. Chondroitin sulfate is most abundant and with age 
chondroitin-4 sulfate is found to decrease while keratin sulfate increases. These changes 
with age or arthritis can directly affect the properties of the cartilage. For example, with age, 
articular cartilage has decreased water content but with osteoarthritis it has increased water 
content (Mankin et al, 2000). 
2.1 Histology of cartilage 
To image articular cartilage, standard hematoxylin and eosin (H&E) is sufficient to visualize 
cartilage damage and clinical use (Fig 2). However, additional stains can provide more 
specific information about the ECM, proteoglycans, and chondrocytes. For proteoglycans 
cationic dyes such as Safranin-O and Alcian blue are typically used. Safranin-O stains 
polysaccharides (both carboxylated and sulfated) orange. Alcian blue can stain for both 
types of polysaccharides (pH 2.5) or be more specific for sulfated polysaccharides (pH 1.0) 
such as chondroitin sulfate, turning them turquoise (Horvai 2011). A Trichrome (Gomori or 
Masson’s) stain highlights the orientation of collagen fibrils with a bright blue stain, while 
staining cytoplasm and other proteins red. Additionally, elastin fibers which are abundant 
in elastic cartilage are typically visualized with a silver stain such as a Verhoff stain where 
the fibers stain black. Cartilage staining can provide clear visualization of the cartilage 
profile in a specific location, however it is more qualitative than quantitative. To obtain 
more quantitative measurements of protein content Polymerase Chain Reaction (PCR) and 
other molecular techniques are needed.   
3. Cartilage injury 
Partial and full thickness cartilage defects have a limited ability for healing. This is in part 
attributed to the avascular properties of cartilage, limited stem cell population, as well as the 
hypoxic environment of diarthrodial joints. Additionally the mechanical loads in the joint 
can make articular cartilage healing a challenge. The full natural history of full thickness 
chondral defects is not well documented in the literature. However it is thought that full 
thickness defects left untreated lead to joint space narrowing and degenerative arthritis 
(Messner & Maletius, 1996). 
Cartilage injuries can occur with a twisting, shearing type injury in combination with 
axial loading. These defects are commonly associated with concomitant knee pathology 
such as meniscus tears, anterior cruciate ligament tears, medial collateral or lateral 
collateral ligament tears. There is a 5-10% incidence of full thickness chondral lesions 
following acute hemarthrosis (Noyes et al, 1980). In athletes, there is approximately a 36% 
prevalence of full thickness focal chondral defects, with 14% being asymptomatic 
(Flanigan et al, 2010). 
Patients who have symptomatic chondral lesions typically present with pain localized to the 
compartment of injury, increased with weight-bearing of that compartment. They may also 
have recurrent effusions, catching, locking, or other mechanical symptoms. The physical 
examination typically will demonstrate crepitance, joint effusion, tenderness along ipsilateral 
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joint line, signs of concomitant injury (meniscus or ligamentous), or malalignment. Coexisting 
malalignment can contribute to chondral injuries, i.e. patella maltracking, high Q angle, tight 




Fig. 2. This figure demonstrates how cartilage can be visualized differently with varying 
histological stains. From left to right: hemotoxylin & eosin (H&E) shows cellular content,  
Safranin-O highlights proteoglycan content, Masson’s Trichrome shows collagen fibers and 
orientation of fibers, and immunohistochemistry can illustrate the different collagen types. 




Fig. 3. Illustration of lateral patellar maltracking and its effects on chondral wear in the 
patellofemoral joint. (A) Radiograph with lateral patella maltracking, and (B) arthroscopic 
view showing chondral injury in a patient with lateral patella maltracking and the “kissing 
lesion” associated. 
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4. Cartilage regeneration methods 
In 1959, abrasion arthroplasty was developed by Pridie to address chondral defects (Pridie, 
1959). Originally developed as an open procedure, it was later adapted for arthroscopy by 
Johnson (Johnson, 1986). Today, abrasion arthroplasty is used primarily for osteoarthritic 
knees. However, for small focal chondral defects, microfracture is most commonly used. 
Microfracture is a marrow stimulating technique that penetrates the subchondral bone in the 
cartilage defect (Fig 4). This allows marrow to communicate with the cartilage defect 
populating it with MSC, inflammatory mediators, and blood. This technique is simple to 
perform and has good to excellent clinical results (Gill, 2000; Steadman et al, 2003; Asik et al, 
2008). Postoperative management requires prolonged non-weight-bearing (4 to 6 weeks) 
followed by the use of continuous passive motion. However, microfracture generates 
fibrocartilage in the defect and has a shorter functional lifespan compared with hyaline 
cartilage (Menche et al, 1996; McGuire et al, 2002; Steinwachs et al, 2008). 
 
 
Fig. 4. Marrow stimulation with: (A) microfracture provides a source of (B) blood cells and 
bone marrow mesenchymal stem cells for cartilage regeneration. Healing response typically 
results in fibrocartilage formation. 
Other techniques to address focal cartilage defects are osteoarticular transfer system with 
auto/allograft transplantation (OATS). This technique involves transplanting the defect 
with an intact cartilage and subchondral bone plug. This technique is typically used for 
small to medium sized lesions (0.5-3cm2) (Fig 5). If a larger area is to be addressed a 
mosaicplasty is performed with multiple plugs. The main disadvantages are donor site 
morbidity, breakdown between the implanted cartilage and subchondral bone, gaps that 
remain between plugs, as well as technical difficulty. 
More recently autologous chondrocyte implantation (ACI) was developed to regenerate 
cartilage closer to hyaline cartilage. This technique can be used for larger defects (2-10 cm2), 
in patients who are symptomatic, and primarily located on the femoral condyles. To 
perform ACI requires 2 stages. The first stage involves harvesting cartilage from a biopsy to 
acquire cartilage cells. These cells are cultured to produce expanded autologous 
chondrocytes, which are subsequently implanted in the defect and held in place with a 
periosteal patch or collagen sheet sewn in place and sealed with a fibrin glue (Gooding et al, 
2006). The postoperative course is challenging with a prolonged course of protected weight-
bearing and continuous passive motion for 4 to 6 weeks. It can take up to 1-1.5 years for 
larger lesions to fill in. Second generation ACI is currently undergoing development to 
overcome the technical disadvantages of the first generation. Second generation ACI uses 
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tissue engineered 3- dimensional scaffolds that are seeded with autologous chondrocytes to 
promote cartilage regeneration. Despite continued technological improvements, clinical 
outcomes have yielded primarily symptomatic relief with fibrocartilage generation. The 
regeneration of long lasting hyaline cartilage continues to be a challenge (Ossendorf et al, 
2007; Tuan, 2007). 
 
 
Fig. 5. Transfer system with auto/allograft transplantation (OATS) is illustrated in this 
figure with (A) harvesting and (B) second-look at one year showing chondral defects 
between the osteochondral plugs. 
5. Adjuncts to current methods 
Recent literature has illustrated that postoperative additions of HA to arthroscopic cartilage 
procedures yield better results (Johnson 1986; Kujawa & Caplan 1986; Gill, 2000; Freedman 
et al, 2004; Jakobsen et al, 2005; Gooding et al, 2006; Lee et al, 2007; Kang et al, 2008; Horvai 
et al, 2011; Fortier et al, 2011). High molecular weight hyaluronic acid is a component found 
in synovial fluid that has been investigated as adjunct for full thickness cartilage injury, 
microfracture, mesenchymal stem cells, and osteochondral allografting. Studies indicated 
that hyaluronic acid may play a role with differentiation of stem cells to chondrocytes, 
decreased joint inflammation, increased proteoglycan content, improved histologic scores, 
defect filling and incorporation, as well as decreased friction in the joint. 
Another approach in attempts to regenerate hyaline cartilage are to use cells delivered either 
seeded on a matrix or transplanted to the defect similar to ACI. There are many cells that 
have been investigated, these include: mesenchymal stem cells (adipose versus bone 
marrow derived), chondrocytes, periostium, perichondrium. Short term results for these 
cellular based treatment modalities have been positive. However, long term clinical results 
are uncertain and have had limitations. Chondrocytes for example, lose chondrocyte 
phenotype with monolayer cell culture expansion and change to a fibroblastic appearance. 
When chondrocytes are combined with matrix/scaffold materials the result is 
predominately fibrocartilage. Perichondral/periosteal cells also have chondrogenic potential 
in vitro and in vivo when seeding matrices. However limitations have included, variable 
results, the need for 2 surgeries for harvest and implantation, and instability of repair tissue. 
Mesenchymal stem cells either adipose derived or bone marrow derived have multilineage 
potential and in the appropriate microenvironment will differentiate to chondrocytes. In 
vivo studies have yielded short term success in generating hyaline cartilage. However, long 
www.intechopen.com
 Articular Cartilage Regeneration with Stem Cells 
 
135 
term results and stability of the repair tissue remain to be demonstrated (Steinert et al, 2007). 
Stem cell transplantations are widely used in treatments where they are induced to 
differentiate into specific cell types required in repairing damaged or destroyed cell tissues 
(Chung et al., 2006). Stem cells are capable of differentiating in vitro and in vivo along 
multiple pathways that include bone, cartilage, cardiac and skeletal muscle, neural cells, 
tendon, adipose, and connective tissue (Panagiota et al., 2005). There has been a vast and 
increasing interest in the research and application of human mesenchymal stem cells 
(hMSC) in the area of regenerative medicine over the last decade. The reasons are due to the 
multipotency and stability of the cellular characteristics of hMSC. However, stem cell 
growth and differentiation, particularly for hMSC, requires a complex and tightly regulated 
system consisting of medium, growth factors and serum components. 
hMSC has been studied for many years and there are a set of tests that can be performed as 
the minimal criteria for defining multipotency of mesenchymal stromal cells (Dominici et al, 
2006). These are: 
1. Plastic adherent assessment: hMSC is known to be able to adhere to plastic and hence 
the first observation is whether the cultured hMSCs exhibit the “plastic-adherent” 
behaviour using standard tissue culture flasks at standard culture conditions. 
2. Surface antigen expression: more than 95% of the hMSC population is to express 
positive for CD105, CD73 and CD90. These can be easily measured using flow 
cytometry. In addition, the cells have to show negative expression (less or equal to 2%) 
of CD45, CD34, CD14 or CD11b, CD79a or CD19 and HLA class II. 
3. Multipotent differentiation potential assessment: One of the criteria that defines 
hMSC is that the cells must differentiate under in vitro culture conditions to 
osteoblasts, adipocytes and chondroblasts. The identification of these differentiated 
cells can be done via Alizarin Red or von Kossa staining (for osteoblast), Oil Red O 
(for adipocytes) and Alcian blue or immunohistochemical staining for collagen type II 
(for chondroblasts). 
There are numerous reports in the literature using MSC to regenerate bone and cartilage. A 
few of the examples are outlined in Table 1 below. Generally, the use of MSC will involve 
either direct injection or incorporation with a scaffold or matrix to aid delivery of the cells to 
the intended site (Nöth et al, 2008). Nevertheless, not all cases use MSC directly, most often 
the MSC are differentiated in vitro for various purposes. This involves some form of 
benchtop work either with isolation of cells or culture expansion thus leading to increased 
costs. 
The literature has not shown any strong evidence that any of the above methods actually 
generated fully function cartilage matching the original cartilage although evidence has 
suggested an improvement of the condition with these treatments. It is theorized that MSC 
have an unknown number of bioactive molecules that are immunoregulatory and able to 
promote regenerative activities (Chen et al 2006 & Uccelli et al, 2007). There are cases 
whereby MSC are used with or without a matrix as a vehicle to deliver gene therapy site 
specific. However, these are still experimental and will not be covered in this chapter. 
Additional approaches to regenerate hyaline cartilage are to adjunct bone marrow 
stimulation with growth factors and hyaluronic acid which is rich in glycosaminoglycans 
and provide the building blocks necessary for cartilage regeneration. Investigators are 
beginning to evaluate platelet rich plasma (PRP). There are numerous proteins found in 
platelets including growth factors involved in the healing response such as platelet derived 
growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth 
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factor (TGF-M1), fibroblast growth factor (FGF). Early research has shown that 
mesenchymal stem cells and chondrocytes exposed to PRP have increased cell proliferation 
and production of proteoglycans and collagen type II (Fortier et al, 2011). In a clinical cohort 
comparing hyaluronic acid with PRP injections, PRP had improved pain scores (Sanchez et 
al, 2008). However, the quality and longevity of the repair tissue generated by the adjunct of 








Autologous mesenchymal stem cells 
seeded onto Gelform scaffold containing 
TGF-β1 growth factor, then transplanted 







Direct intra-articular injection of 
autologous mesenchymal stem cells 







Direct intra-articular injection of 
autologous mesenchymal stem cells in a 
dilute solution of hyaluronic acid  







Autologous mesenchymal stem cells 
seeded with collagen type I hydrogels 





Table 1. Examples of clinical applications of hMSC 
6. Arthroscopic subchondral drilling augmented with peripheral blood 
progenitor cells (PBPC) 
Our laboratory has had increased interest in the used of peripheral blood progenitor cells 
(PBPC) over the use of bone marrow derived progenitor cells (BMPC). A study report 
published in April 2011 by the first author’s group (Saw et al, 2011) confirmed that 
articular hyaline cartilage regeneration was possible with arthroscopic subchondral 
drilling followed by postoperative intraarticular injections of autologous PBPC in 
combination with HA. 
Treatment involving progenitor cells stems from the hematology/oncology profession: Given 
the potential morbidity associated with iliac crest harvest, cell collection for bone marrow 
repopulation now involves mobilization of multipotential progenitor cells through hormonal 
stimulation and collection via a peripheral automated cell separator machine. This process, 
commonly referred to as apheresis, has potential for increased magnitude of harvest. Studies 
involving review of healthy donors have shown this to be a safe and effective procedure for 
the production and harvest of cells (Ceselli et al, 2009 & Holig et al, 2009). Recent study into 
the properties of these PBPC has shown that they are similar to embryonal stem cells in that 
they express transcription factors specific to pluripotential cells, have proliferative potential, 
have the ability to differentiate into a multitude of cell types, and are more immature than 
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BMPC (Ceselli et al, 2009). In addition, when injected subcutaneously into mice, these cells 
were found to migrate to multiple organs and integrate and function as the surrounding cells 
(Ceselli et al, 2009). In addition to implementing evidence from recent animal studies, we have 
sought to make use of clinical evidence regarding the potential and safety of PBPC, preferring 
to use PBPC as opposed to BMPC because of the ease of harvest, decreased harvest-site 
morbidity, and increased potential with these cells (Ceselli et al, 2009; Holig et al, 2009 & 
Ordemann et al, 1998). In the clinical setting, we prefer to use PBPC as opposed to BMPC due 
to the ease of harvest and the increased potential with these cells. Subsequently, we have 
developed a method involving standard marrow stimulation in the form of subchondral 
drilling and novel postoperative intraarticular injections of autologous PBPC in combination 
with HA to regenerate articular cartilage. 
7. Authors preferred method 
7.1 Evolution of technique 
Arthroscopic surgeons are regularly faced with the challenges of providing a satisfactory 
end result for the treatment of chondral lesions. Prior to the development of the current 
method, the first author was treating chondral lesions with standard subchondral drilling 
followed by postoperative intraarticular injections of hyaluronic acid (HA). This being a 
variant of marrow stimulation technique, produces fibrocartilage which is not as resilient as 
the original hyaline cartilage. The newly regenerated fibrocartilage gradually deteriorated 
with time. Since Year 2005, the first author has been dissatisfied with the inconsistent end 
results following this method of cartilage repair as shown in Fig 6. 
 
 
Fig. 6. Intraoperative view after subchondral drilling of the lateral patella facet - right knee 
(A). Second-look at 18 months (B) showing partial coverage of the defect with fibrocartilage.  
At the same time, veterinary surgeons have shown that injections of bone marrow aspirate 
into race horse’s flexor tendon injuries resulted in satisfactory healing (Pacini et al, 2007; 
Taylor et al, 2007; Thomas et al, 2008 & Violini et al, 2009). This gave rise to the idea of 
utilizing stem cells in the knee joint to initiate articular cartilage repair after subchondral 
drilling. 
A literature search suggests that the mesenchymal stem cell (MSC) is a better alternative 
to the chondrocyte as it is a less differentiated cell and is capable of differentiating into 
both bone and articular cartilage. As most chondral lesions involve both these 
components, cells that are capable of forming both bone and cartilage should theoretically 
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be able to regenerate into tissue that will integrate better with the surrounding native 
structures. This may minimize  of delamination which is occasionally seen by the 
autologous chondrocyte implantation (ACI) technique. Fig 7 shows the potential 
differentiation process of MSC. 
 
 
Fig. 7. Potential differentiation process of MSC. 
Open surgery does not appeal to arthroscopic surgeons. The ideal method of articular 
cartilage repair would be a single arthroscopic procedure followed by an adjunct cell 
therapy which could be performed in the out-patient setting. Obviously the desired end 
result should be the regeneration of the original hyaline cartilage with clinical improvement. 
The arthroscopic surgeon’s wish list for chondrogenesis is listed below: 
 Single arthroscopic procedure 
 Able to treat multiple/kissing lesions 
 Applicable in large osteochondral defects 
 Simple delivery – intraarticular injections 
 Scaffold free 
 Treat associated injuries 
 Regeneration of soft tissues 
 Cost effective 
 Hyaline cartilage regeneration 
7.2 Animal model 
The following work has been published in Arthroscopy: The Journal of Arthroscopic and 
Related Surgery, Vol 25, No 12 (December), 2009: pp 1391-1400 (Saw et al, 2009). An excerpt 
of the published work is described. 
Hemopoetic stem cell 
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In the animal model, we wished to find out whether postoperative intraarticular injections 
of autologous marrow aspirate (MA) and HA after subchondral drilling could result in a 
better cartilage repair. 
A 4 mm full thickness articular cartilage defect was created in the stifle joint, followed by 
subchondral drilling as shown in Fig 8. The animals were divided into three groups: group 
A (control), no injections; group B (HA), weekly injection of 1 mL of sodium hyaluronate for 
3 weeks; and group C (HA + MA), similar to group B but with 2 mL of autologous MA in 
addition to HA. MA was obtained by bone marrow aspiration, centrifuged, and divided into 
aliquots for cryopreservation. 15 animals were equally divided between the groups and 
sacrificed 24 weeks after surgery, when the joint was harvested, examined macroscopically 
and histologically (Fig 9). 
 
 
Fig. 8. (A&B) A 4mm full thickness articular cartilage defect was created in the stifle joint, 
followed by subchondral drilling. 
7.2.1 Macroscopic findings 
The chondral defects were covered with repair tissue in all groups, without evidence of 
synovitis or synovial thickening (Fig 9). In group A the defects were covered with 
semitransparent tissue having recognizable margins but with an irregular surface. A similar 
appearance was seen in group B goats. In group C the defect coverage was almost complete, 
and the color of the repair tissue was indistinct from surrounding cartilage. The surfaces 
were smooth and appeared level with adjacent normal cartilage. 
7.2.2 Histologic findings 
Under H&E staining, scar tissue was present in group A, which was characterized by a 
disordered arrangement of fibroblasts in an edematous stroma (Fig 9). The interface of scar 
tissue with subchondral bone was marked by the presence of dilated capillaries and venules. 
In group B scar tissue was less pronounced, and islands of hyaline-like cartilage were seen 
at the interface with subchondral bone and also adjacent to normal cartilage at the defect 
margins. Edema was also less marked than in the control group. In group C there was 
chondrogenesis with evidence of hyaline cartilage formation. The hyaline cartilage also 
showed features of maturation as evidenced by a linear arrangement of chondrocytes 
extending from the subchondral bone toward the surface. No edema was seen in this group.  
With Safranin-O staining, proteoglycans were notably absent from the repair tissue in 
group A. In group B proteoglycans were seen only at the base and sides of the defect in 
the same distribution as the hyaline-like cartilage. In group C there was marked 
proteoglycan accumulation in the deeper layers, excluding the perichondrium, which 
normally does not contain proteoglycans. 
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Under collagen staining, the scar tissue in group A was found to contain only type I 
collagen, with an absence of staining for type II collagen. In group B type I collagen staining 
in the repair tissue was less pronounced, with light staining for type II collagen around the 
areas of hyaline-like cartilage. In group C type I collagen staining was found only in the 
perichondrium, whereas the deeper cartilage stained strongly for type II collagen.  
 
 
Fig. 9. Macroscopic and histologic findings for representative subjects from all 3 groups. (N, 
normal cartilage; R, repair cartilage; V, dilated capillaries and venules; I, islands of hyaline-
like cartilage). 
7.2.3 Discussion on the animal model 
Penetration of the subchondral bone was shown to release the underlying marrow, which 
initiated repair of the chondral defect with fibrocartilage in a pattern that was observed in 
group A animals. The reason why fibrous tissue forms instead of hyaline cartilage is not 
known, but it is likely that the local microenvironment contains paracrine factors that either 
promote fibrous tissue formation, inhibit cartilage growth, or both. 
The addition of HA in group B animals improved the quality of repair tissue by allowing 
hyaline-like cartilage to form. This suggests that HA modifies the microenvironment in such 
a way that neutralizes these paracrine factors. The incomplete regeneration could be because 
of HA being only partially effective or the duration of administration being too short. It 
appeared that the region adjacent to subchondral bone and the interface with normal 
cartilage seemed to be most favorable to cartilage formation. 
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The combination of HA and MA in group C yielded the best results in that the repair tissue 
was composed of true hyaline cartilage, showing vertical orientation of chondrocyte nests 
and the presence of type II collagen and proteoglycans in the intermediate and deep 
cartilage layers, with type I collagen confined to the superficial layer and perichondrium 
(Fig 9). This suggests that the combination of HA and MA is most effective in neutralizing 
the paracrine factors, and its effects persist for the duration of the repair process. One of the 
essential active components in MA is likely the MSC content, given that a previous study in 
a porcine model showed that cultured autologous MSCs injected intraarticularly together 
with HA could produce the same results as in the group C animals (Lee et al, 2007). 
The presence of edema in the repair tissue appears to be proportional to the degree of fibrous 
scarring and was most marked in group A animals. The dilated capillaries and venules at the 
base of the defect suggest an inflammatory process that originates in the subchondral bone. 
These observations indicate that the paracrine factors, which promote fibrous tissue formation, 
are closely related to the inflammatory process that occurs after mechanical disruption of the 
chondral plate and that both HA and MA may be able to suppress inflammation locally. 
7.2.4 Conclusion on the animal model 
This preclinical experimental study in the goat model concluded that postoperative 
intraarticular injections of autologous MA in combination with HA after subchondral 
drilling resulted in a better cartilage repair. 
7.2.5 Clinical relevance from the animal model 
After arthroscopic subchondral drilling, postoperative intraarticular injections of autologous 
progenitor cells in combination with HA may result in better articular cartilage regeneration. 
7.3 Clinical trial 
A human clinical trial followed the preclinical animal studies. The surgical technique 
applied in the clinical trial involved standard marrow stimulation in the form of 
arthroscopic subchondral drilling and postoperative intraarticular injections of autologous 
peripheral blood progenitor cells (PBPC) in combination with HA. The objective of the trial 
was to assess whether the results of the preclinical animal model could be replicated in the 
human knee joint. The purpose of the clinical trial was to evaluate the quality of resultant 
articular cartilage regeneration. A hypothesis was made that articular hyaline cartilage 
regeneration was possible with this novel approach. 
The early results with histology were published in Arthroscopy: The Journal of Arthroscopic and 
Related Surgery, Vol 27, No 4 (April), 2011: pp 493-506 . An excerpt of the paper is presented in 
the following sections (Saw et al, 2011). 
7.3.1 Patient selection – indication for surgery 
The diagnosis of chondral injury was made after clinical and radiologic evaluation. Chondral 
lesions were graded according to the International Cartilage Repair Society (ICRS) Cartilage 
Injury Evaluation Package (Brittberg & Peterson, 1998) The inclusion criteria were patients 
with ICRS grade III and IV lesions, defects of any size and number, age 18 to 60 years, 
deformity (lateral patella maltracking or axis correction) correctable at the time of surgery, and 
ligamentous instability deemed reconstructable at the same time. The exclusion criteria were 
patients with disease progression such that total knee arthroplasty was indicated; a history of 
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infected knees, gross bone defects, rheumatoid arthritis, or intraarticular corticosteroids within 
the previous 6 weeks; and gross valgus or varus deformity not correctable during surgery. 
7.3.2 Surgical procedure 
All surgical procedures were performed by a single surgeon (by the first author) involving 
standard arthroscopic techniques in the supine position without a tourniquet. Saline solution 
irrigation bags were chilled in an ice-water bath before use to minimize bleeding during the 
arthroscopic procedure. In our experience, we have had difficulty performing microfracture to 
the patella and areas of the plateau. For this reason, our preferred method is arthroscopic 
subchondral drilling modified from the principles established by Steadman et al (Steadman et 
al, 1999), for microfracture and Pridie (Pridie, 1959) for drilling. We begin by defining the 
extent of cartilage injury with a probe. A 3.5 mm full-radius shaver is used to debride loose 
cartilage to a stable margin; often a straight or curved arthroscopic biter is required as well. A 2 
mm burr, with its guard removed, “drills” from the surface of the defect to the bone marrow, 
creating a conduit. The remaining area within the margin is also drilled to a depth of 5 to 10 
mm. Initially, we spaced drill holes 3 to 4 mm apart. The methods have subsequently been 
refined such that a goal of 1 to 2 mm between drill holes is now preferred based on the results 
of second-look arthroscopy. It is not crucial that the subchondral drilling be performed 
perpendicular to the bone surface because a lesser angle of drilling capable of penetrating into 
the subchondral bone is sufficient. Abrasion chondroplasty up to a depth of 1 mm is 
performed with burring of the bony area between drill holes. The result is an extended area of 
bleeding bone, hence a larger surface area for the initiation of articular cartilage repair with 
PBPC and HA (Fig 10). The arthroscopic portals are closed with No. 3-0 nylon suture. A 
mixture of 20 mL of 0.5% bupivacaine hydrochloride and epinephrine, 3 mL of 1 mg/mL 
morphine, and 2 mL of HA (Hyalgan; Fidia Farmaceutici, Abano Terme, Italy) is injected into 




Fig. 10. Subchondral drilling. (A) A delaminated flap tear on the medial & central trochlear 
of a left knee. (B) A 2 mm burr with guard removed allows for drilling with light suction. 
(C) View after debridement, subchondral drilling and abrasion chondroplasty. 
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7.3.3 Postoperative rehabilitation 
Cold therapy is initiated for one hour 2 to 3 times a day immediately in the postanesthesia 
period and continued throughout the first month after surgery. On the first postoperative 
day, continuous passive motion is used on the operated knee for a duration of 2 hours (Fig 
11). This is continued daily for a period of 4 weeks. The range of motion is initially set from 
0° to 30° and progresses as the clinical situation improves. Patients with subchondral 
drilling to the weight-bearing femorotibial joint are instructed on crutch-assisted partial 
weight-bearing (15 to 20 kg) for the first 4 weeks. This progresses to full weight-bearing in 6 
to 8 weeks. Patients with drilling to the patellofemoral joint are allowed full weight-bearing 
as tolerated with restrictions from weight-bearing on stairs for the first 3 months after 
surgery. This is to avoid overloading the patellofemoral joint. 
 
 
Fig. 11. Patients undergoing postoperative rehabilitation (A). A closer view of patients 
showing continuous passive motion applied on the operated knee (B). 
7.3.4 Neupogen administration, apheresis, and cryopreservation 
Human granulocyte colony–stimulating factor is a glycoprotein that regulates the 
production and release of functional neutrophils from the bone marrow. Neupogen contains 
recombinant granulocyte colony–stimulating factor and causes marked increases in 
peripheral blood neutrophil counts with a minor increase in monocytes within 24 hours. On 
postoperative days 4, 5, and 6, patients were given a morning dose of 300 micro-grams of 
Neupogen (Filgrastim, Amgen, Thousand Oaks, CA) subcutaneously. On postoperative day 
7, autologous PBPC were collected by an automated cell separator (apheresis) via central 
venous access. Venous access was achieved through a femoral double-lumen catheter placed 
into the contralateral leg, under ultrasound guidance, performed by a trained specialist. 
Apheresis was performed by use of the Spectra Optia Apheresis Machine (Caridian BCT, 
Denver, CO). A fresh aliquot of 8 mL of PBPC was separated for fresh intraarticular injection 
into the operated knee. The remaining PBPC were cryopreserved in 10% dimethyl sulfoxide 
and divided into 4 mL cryovials for storage in liquid nitrogen at –196°C. Flow cytometry 
with CD34+ (hematopoietic stem cells) and CD105+ (markers for mesenchymal stem cells) 
was quantified. Flow cytometry was performed with a Beckman Coulter FC500 device 
(Beckman Coulter, Fullerton, CA). Fig 12 showing the apheresis process. The 
cryopreservation of the harvested PBPC in cryovials can be seen in Fig 13. 
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Fig. 13. Cryopreservation of the harvested PBPC in cryovials. 
7.3.5 Intraarticular injection 
On postoperative day 7, 8 mL of the fresh PBPCs is mixed with 2 mL of HA and injected into 
the operated knee joint under aseptic conditions in the out-patient clinic. Prior to this, the 
knee is first aspirated for hemarthrosis. At weekly intervals, 8 mL (from two 4 mL cryovials) 
of the frozen PBPC were obtained from the laboratory, allowed to thaw to room 
temperature, mixed with 2 mL of HA, and injected into the operated knee joint for 4 
subsequent weeks. A flow chart of the protocol for patients undergoing articular cartilage 
regeneration is shown in Fig 14. Table 2 shows the PBPC count of 20 recent consecutive 
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patients after refinement of our processing methods, showing data of fresh and frozen 








White Cell Count 
10³ / uL 
CD 34+ (106) Cells 
per 4ml Vial 
CD 105+ (106) Cells 
per 4ml Vial 
Viability % 
Fresh Frozen Fresh Frozen Fresh Frozen 
 32.00 6.86 4.58 7.42 8.14 99.30 79.90 
 24.40 1.04 0.66 9.98 14.41 99.30 89.65 
 30.00 0.33 0.23 3.32 5.08 99.10 89.99 
 35.60 1.03 0.74 15.44 20.33 99.01 91.97 
 14.80 3.88 2.86 2.69 8.87 99.40 87.90 
 33.50 0.44 0.37 8.95 7.04 99.60 95.30 
 33.50 3.28 2.33 5.41 7.75 99.00 82.90 
 34.80 2.02 1.34 13.60 14.01 99.50 94.04 
 23.00 2.53 1.69 7.01 13.77 99.50 88.10 
 37.10 2.42 1.32 3.37 5.72 98.90 88.10 
 26.50 1.55 1.07 4.54 6.98 99.00 84.80 
 52.10 2.76 2.17 8.89 4.56 99.40 90.30 
 38.80 3.15 1.82 15.50 11.62 99.30 79.30 
 32.10 0.86 0.75 12.79 6.35 98.90 91.30 
 33.00 5.71 3.14 6.30 8.53 99.10 78.40 
 20.00 1.02 0.62 14.80 15.40 97.80 88.40 
 37.50 3.19 2.08 4.15 1.66 99.30 82.20 
 26.90 2.78 1.90 1.43 4.44 99.30 82.30 
 31.00 1.55 1.01 23.45 31.15 99.10 89.10 
 44.60 1.16 0.67 16.62 19.40 98.50 91.80 








Table 2. Example of 20 consecutive PBPC counts from patients following 3 neupogen 
injections. Data of fresh and frozen samples with white cell count, CD34+ and CD105+ 
counts, and cell viability. 
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Fig. 14. Flow chart showing the standard protocol for articular cartilage regeneration with 
PBPC and HA.  
Fresh cells are used preferably for the first injection because of a mean viability of 99% 
compared with frozen cells, which have a mean viability of 87%. It should be noted that 8 
mL of PBPC injected into the operated knee has a mean of 20 million CD105+ cells. 
Historically, the cell marker CD34+ (hematopoietic stem cells) has been used to identify 
functional cells for bone marrow transplant. We have begun to draw interest in CD105+ 
cells, because this is the marker for mesenchymal stem cells.  
Five weekly injections are based on the HA protocol for osteoarthritis, as well as the 
suggestion from preclinical animal studies involving Bone Marrow Progenitor Cells (BMPC) 
that an increased number of intraarticular injections is more efficacious (Saw et al, 2009). 
Table 3 shows the viability of 5 consecutive frozen PBPC samples after mixing with HA. As 
can be seen, there is no effects of HA on the viability of the PBPC. 
 
Frozen PBPC from -196ºc Storage Tank 
Patient 
Before addition of HA After addition of HA 














A 3.000 2.010 75.10% 3.380 6.050 77.50% 
B 1.060 10.800 78.90% 0.980 3.750 83.00% 
C 3.220 16.800 68.20% 2.660 8.230 68.90% 
D 1.020 5.150 85.10% 0.550 2.370 86.60% 
E 0.720 7.710 82.20% 0.750 2.780 84.80% 
AVERAGE 1.804 8.494 77.90% 1.664 4.636 80.16% 
Table 3. Cell count viability. 
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7.4 Introduction to clinical cases 
Five cases are presented here with their respective chondral biopsies and histology. These 
cases provided explanation to the principles of chondrogenesis in our novel approach. 
The patients are part of a larger pilot study in which 180 patients who presented with 
chondral defects of the knee joint were recruited. Postoperatively, the clinical course of these 
5 patients presented an opportunity for a second-look arthroscopy. Two patients underwent 
contralateral knee surgery, and one patient had removal of a Tomofix plate and screw 
construct (Synthes, West Chester, PA), providing an opportune setting of anesthesia for 
second-look arthroscopy. One patient had recurrence of discomfort attributed to a 
prominent osteophyte and elected for a further arthroscopic procedure. The last patient had 
returned to football 18 months after articular cartilage repair and sustained a torn anterior 
cruciate ligament of the previously treated knee. He elected for arthroscopic reconstruction, 
which provided an opportunity for second-look arthroscopy. Informed consent after 
discussion of risks and benefits, as well as local ethics committee approval, was obtained 
before biopsy. 
7.4.1 Second-look arthroscopy with chondral core biopsy 
During the second-look procedures, a chondral core biopsy specimen was procured. This 
was performed arthroscopically with a 5.5 mm sterilized BioCorkscrew anchor driver 
(Arthrex, Naples, FL). Typically, a 2 mm diameter specimen of cartilage together with a core 
of bone up to 1 cm in length is obtained (Fig 15). 
Arthroscopically, the regenerated articular cartilage appeared smooth and had excellent 
integration with the surrounding native cartilage without any delamination or hypertrophy. 
The exception was case 2, in which the drill holes over the lateral patellofemoral joint were 
too far apart with resultant tufts of cartilage seen between areas devoid of regenerated 








Fig. 15. Solid articular cartilage core biopsy with a 2 mm diameter including the underlying 
subchondral bone. 
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Fig. 16. 34-year-old female from Fig 22. Second-look arthroscopy from the lateral patella 
facet and lateral trochlear showed tufts of cartilage forming at each individual drill hole. 
Upon histological stains, notice the red staining with Safranin-O representing proteoglycans 
and the brown staining of collagen type II diffuse throughout the regenerated tissue. 
Collagen type I stain is minimal and localized near the superficial layers.   
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Histologic samples were stained as follows: hematoxylin-eosin (H&E) stain was used to 
visualize overall morphology, Safranin-O was used to highlight proteoglycans, 
immunohistochemistry staining with anti–collagen type I mouse Ab I-8H5 stain (catalog 
No. CP 17; Calbiochem Merck, Darmstadt, Germany) was used to highlight collagen type 
I, and immunohistochemistry staining with anti–collagen type II mouse monoclonal 
antibody Ab 3 (clone 6B3) (catalog No. MAB8887; Millipore, Billerica, MA) was used to 
highlight collagen type II. Optimal dilution and predigestion with pepsin were 
determined by the investigator with the protocol being saved by use of software of an 
automated immunohistochemical slide preparation system (Ventana Benchmark; Ventana 
Medical Systems, Tucson, AZ). 
Cases 1 and 2 with gross grade IV kissing lesions are presented with multiple biopsy 
specimens and histologic analyses after second-look arthroscopy. Cases 3, 4, and 5 are 
patients with smaller isolated lesions. 
Case 1: Biopsy was performed 22 months after the initial surgery in a 49-year-old woman 
with a varus deformity who underwent debridement, subchondral drilling, and an open 
wedge high tibial osteotomy with Tomofix fixation (Fig 17).  
 
 
Fig. 17. Progressive serial weight-bearing radiographs of Case 1 with high tibial osteotomy.  
Notice re-appearance of the medial articulation. 
Approximately 80% of the weight-bearing medial compartment had grade III and IV lesions. 
Weight-bearing radiographs at 8 and 18 months showed reappearance of the medial 
femorotibial joint space. Second-look arthroscopy of the regenerated cartilage showed a 
stable, smooth surface with no delamination. On probing, the regenerated cartilage had the 
same consistency as the surrounding normal cartilage. The second-look images and biopsy 
specimens are included in Fig 18.  
Immunohistochemistry staining was performed to assess the collagen type I and type II 
content of the biopsy specimens. Specimens from the medial femoral condyle and medial 
tibial plateau showed the presence of collagen type I confined to the superficial layer. 
Collagen type II was present throughout the deeper layers. These are features of hyaline 
cartilage as opposed to fibrocartilage (Fig 18). Fig 19 shows a higher magnification of the 
histological sections from the medial tibial plateau. 
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Fig. 18. Medial tibial  plateau (MTP), medial femoral condyle (MFC) and intercondylar notch 
(ICN) biopsy results at 22 months after surgery. Biopsies from the MTP and MFC with H&E 
staining illustrate columnar morphology of cells with pale background. Safranin-O staining 
highlights abundance of proteoglycans throughout the regenerated cartilage layer. Collagen 
type I staining was limited to the superficial layer except in the non-weight-bearing ICN 
biopsy which showed a higher percentage of collagen type I and a disorganized pattern of 
healing.  Collagen type II was concentrated in the deeper layers. 
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One full-thickness biopsy specimen from the medial tibial plateau captured a drill hole and 
adjacent bone (Fig 20). This sample shows full-thickness regenerated articular cartilage with 
a fairly smooth articular surface, subchondral bone, and marrow space. A streaming, linear 
pattern of chondrocytes is seen arising from the subchondral bone region from the area of 
previous subchondral drilling. Incidental findings of cartilage clusters with early ossification 
are also seen within the tract. The chondrocytes are involved in ongoing remodelling and 
are present beneath the calcified cartilage layer. A biopsy specimen from the medial femoral 
condyle of the patient also showed the presence of a previous drill hole lined with 
chondrocytes. This sample illustrated an area of regeneration undergoing ossification, 
showing re-establishment of the calcified cartilage layer and the tidemark (Fig 21). The 
tidemark is seen as an undulating basophilic line on routine H&E staining and is the point at 
which the articular cartilage becomes calcified. The subchondral drill defect area is replaced 
by the presence of chondrocytes with varying degrees of maturation surrounded by a 
ground substance matrix. In addition, ossification is evident with new trabecular bone 














Fig. 19. Biopsy from the medial tibial plateau in case 1 showing the presence of 
chondrocytes and collagen fibres aligning to the axis of weight transmission with their 
specific stains (Original magnification X 100).  
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Fig. 20. (A) H&E sample as in Figure 18  from the medial tibial plateau managed to biopsy 
an area of previous drilling. (B) Upon higher magnification, chondrocytes appeared deep to 
the subchondral bone with areas of ossification. Notice the chondrocytes below the 
subchondral bone region beginning as immature cells (short arrow) and progressing toward 
the joint surface as mature chondrocytes in rows (long arrow). (C) Upon staining with 
Safranin-O, there was a high concentration of proteoglycans at the base of the regenerated 




Fig. 21. A biopsy from the medial femoral condyle illustrating ossification of regenerated 
cartilage and the re-establishment of the calcified cartilage (white arrow) layer with 
tidemark (black arrow). Note the presence of chondrocytes below the calcified cartilage 
(double arrow) with areas of ossification.   
www.intechopen.com
 Articular Cartilage Regeneration with Stem Cells 
 
153 
The intercondylar notch sample was an area of previous roof-plasty and notchplasty with 
abrasion chondroplasty. This represents an area that is non–weight-bearing. Histologic 
biopsy examination here showed a mixed tissue with fibrocartilage and hyaline-like 
cartilage: the predominance of collagen type I, less collagen type II, and chondrocytes 
arranged in a more disorganized pattern. We believe that the failure of the chondrocytes to 
exhibit a linear streaming pattern, as seen from the medial tibial plateau and medial femoral 
condyle biopsy specimens, is due to the absence of stimulation from weight-bearing forces 
on the intercondylar notch (Fig 18). 
Case 2: A chondral core biopsy specimen was taken 26 months after surgery in a 34-year-old 
woman with previous multiple open surgeries for recurrent dislocation of the patella as an 
adolescent. She underwent arthroscopic debridement, lateral patella release, and 
subchondral drilling. There were grade III and IV lesions over the entire patellofemoral 
joint. Preoperative merchant-view radiographs showed severe patellofemoral osteoarthritis, 
a large medial trochlear osteophyte, and absence of the lateral patellofemoral joint space (Fig 
22). During arthroscopic surgery, the medial trochlear osteophyte was burred and 
subchondral drilling was performed on the entire patellofemoral joint. An immediate 
postoperative radiograph showed evidence of subchondral drilling. Radiographs at 6 
months and 2 years showed progressive reappearance of the lateral patellofemoral joint 
space (Fig 22). Fig 16 contains results of the second-look arthroscopy with chondral core 
biopsy specimens. The lateral patella facet and lateral trochlear areas showed tufts of 
cartilage between areas devoid of cartilage. In contrast, the medial trochlear area that 
underwent the removal and burring of a large osteophyte followed by subchondral drilling 






Fig. 22. 34-year-old female with recurrent dislocation of her patella as an adolescent. 
Immediate postoperative radiographs showed evidence of subchondral drilling while 
radiographs at 6 months and 2 years showed a progressive reappearance of the lateral 
patellofemoral articulation. 
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Case 3: A biopsy specimen was obtained 1 year after surgery from a 52-year-old woman 
with an isolated grade IV lesion of the lateral femoral condyle measuring 2 X 1 cm. 
Case 4: A biopsy specimen was obtained 10 months after surgery in a 43-year-old woman 
with lateral patellar maltracking. There was a grade III/IV defect measuring 2.5 X 3.5 cm 
over the lateral patella facet. Lateral patella release was performed in addition to 
subchondral drilling. 
Case 5: Biopsy was performed at 18 months after surgery in a 19-year-old man with lateral 
patellar maltracking and a lateral trochlear grade IV lesion measuring 0.8 cm in diameter. 
Subchondral drilling was performed followed by lateral patellar release (Fig 23). 
Chondral core biopsy specimens in cases 2, 3, 4, and 5 with histologic staining with H&E 
showed columnar morphology of cells with a pale blue ground substance. Safranin-O 
showed intense orange / red staining of the newly regenerated cartilage zone throughout 
the regenerated cartilage layer with a propensity toward the deeper areas of cartilage above 
the subchondral bone. The matrix also showed a predominance of collagen type II deposits, 
whereas collagen type I was minimal and located mostly over the superficial regions of the 
articular surface. These compositional results are features of hyaline as opposed to 
fibrocartilage (Kang et al, 2008; Saw et al, 2009 & Lee et al, 2007). 
 
 
Fig. 23. Second-look arthroscopy and histological images of a lesion from the lateral femoral 
condyle (Case 3), a lesion from the lateral patella facet (Case 4) and a lesion from the lateral 
trochlear (Case 5).  
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7.4.3 Chondrogenesis with PBPC and HA 
Findings from second-look arthroscopy presented in the above 5 case series confirmed that 
it was possible to replicate the results of our animal model (Saw et al, 2009) in the human 
knee joint using a combination of postoperative intraarticular injections of autologous PBPC 
with HA after arthroscopic subchondral drilling. This method uses marrow stimulation to 
create an autologous scaffold that is subsequently seeded with both intraarticular injections 
of autologous PBPC and in-situ progenitor cells from the underlying marrow (Fig 24). 
7.4.4 Contained lesion 
In a typical chondral lesion of the medial femoral condyle (Fig 24) measuring 2cm x 2cm, 





Fig. 24. Chondrogenesis: Contained lesion. (A) A blood clot scaffold is formed after 
subchondral drilling and abrasion chondroplasty between the drill holes. The surrounding 
articular cartilage is normal with the underlying calcified cartilage layer and subchondral 
bone. (B) Injection of fresh PBPC plus HA 1 week after surgery results in the homing of the 
PBPC into the blood clot scaffold. (C) The PBPC residing in the osteochondral junction and 
blood clot scaffold gradually transform to chondrocytes. HA helps to reduce inflammation 
and provide raw material for chondrogenesis. The injected PBPC exert paracrine effects and 
recruit in-situ progenitor cells to assist in chondrogenesis. Repeated injections of PBPC plus 
HA enable more cells to be recruited into the chondral defect and enhance chondrogenesis. 
(D) The final result is the formation of a new layer of articular cartilage with good 
integration to the surrounding tissues. The ossification of the chondrocytes below the 
articular cartilage results in repair of the subchondral bone with re-establishment of the 
calcified cartilage layer. 
www.intechopen.com
 Modern Arthroscopy 
 
156 
7.4.5 Uncontained Lesion – Sparse drilling 
Second-look arthroscopy in case 2 revealed tufts of cartilage in between areas devoid of 
regenerated cartilage. The subchondral drilling over the lateral patellofemoral joint was 
spaced at 3 to 5 mm apart. Fig 25 provides an explanation. As a result, we have refined our 
techniques so that a goal of 1 to 2 mm between drill holes is now sought. Abrasion 






Fig. 25. Chondrogenesis: Uncontained lesion—sparse drilling. (A) In large chondral defects 
with areas of bare bone, the only available blood clot scaffold is from the areas after 
subchondral drilling. (B) Injection of fresh autologous PBPC plus HA 1 week after surgery 
will result in the homing of the PBPC into the subchondral blood clot scaffold, with the 
PBPC residing in the blood clot scaffold. (C) Because there is no blood clot scaffold 
superficial to the subchondral bone, chondrogenesis can only be achieved by the protruding 
tufts of cartilage from the subchondral bone drilling. (D) If the subchondral drill holes are 
placed too far apart, the end result is the incomplete coverage of the subchondral bone with 
individual tufts of cartilage seen between areas devoid of cartilage. 
7.4.6 Uncontained Lesion – Ideal drilling 
Ideally placed drill holes with abrasion chondroplasty allows for a larger surface area and 
volume of blood clot scaffold to form. When seeded with PBPC and HA, chondrogenesis 
progresses evenly and the individual tufts of growing cartilage coalesce to form a new layer 
of articular hyaline cartilage. 
Our current method of subchondral drilling in large uncontained lesion is shown in Fig 26. 
www.intechopen.com





Fig. 26. Chondrogenesis: Uncontained lesion—ideal drilling. (A) Ideally placed subchondral 
drilling (1 to 2 mm apart) and abrasion chondroplasty between the drill holes increase the 
available bony areas for the homing of the PBPC. (B) Injected PBPC and HA have a larger 
surface area of raw bone providing homing signals for the recruitment of the PBPC. (C) 
Individual tufts of cartilage arise from the subchondral bone and coalesce to cover the bony 
defect. (D) Maturation will result in an increase in thickness of the regenerated cartilage 
covering the entire defect. 
7.4.7 Further cases to support the theory of chondrogenesis with ideal drilling in 
uncontained lesion 
The following cases illustrate the advances made in the light of the histological findings 
following second-look arthroscopy as regards to the importance of meticulous surgical 
technique, adjuvant PBPC & HA therapy and cell viability. 
Chondral lesions in difficult to access region of the knee joint presented a special challenge 
to treatment. An example would be the posterior aspects of the medial and lateral tibial 
plateau. In the early phase of the clinical trial, the first author used a technique called the 
“Inkwell” (Fig 27) procedure in which a 4 mm burr was used to create multiple half moon-




Fig. 27. Illustration of an “Inkwell” procedure.  
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Case 6: A 53-year-old man with a varus knee presented with the loss of the articular 
cartilage over the medial compartment. He underwent a high tibial osteotomy with the 
fixation of a Tomofix plate. Postoperative intraarticular injections of PBPC in combination 
with HA were given in accordance with the standard protocol. 
The medial femoral condyle underwent ideal subchondral drilling of the uncontained lesion 
(Fig 28). In the medial tibial plateau, ideal subchondral drilling was performed over the 
anterior half of the tibial plateau. Due to poor access, it was not possible to perform 
subchondral drilling over the posterior half of the tibial plateau. Therefore the “Inkwell” 




Fig. 28. The corresponding arthroscopic views over the medial femoral condyle. (A) 




Fig. 29. (A) Arthroscopic view with black arrow showing ideal subchondral drilling over the 
anterior half of the medial tibial plateau. Red arrow showing the multiple “inkwells” 
created in the posterior half of the medial tibial plateau. The blue line indicates the border 
separating the two distinct procedures. (B) Second-look arthroscopy at 18 months showing 
ideal chondrogenesis in the anterior half of the tibial plateau as compared to the posterior 
half. 
Fig 30 shows the radiological reappearance of the medial articulation at 7 months after 
surgery. MRI scan at 18 months confirmed the presence of repair cartilage over the anterior 
half of the medial compartment (Fig 31), confirmed on second-look arthroscopy (Fig 29). 
This is in contrast with the repair appearance of the posterior half of the tibial plateau (Figs 
29 and 32). 
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Fig 30. A 53-year-old male underwent high tibial osteotomy: (A) Preoperative XR showing 
narrowing of medial compartment; and (B) Postoperative view at 7 months showing re-






Fig. 31. Preoperative (Pre-op) MRI (STIR) showing ‘bone on bone’ over the medial 
compartment of the right knee (red arrow). White arrow showing regenerated articular 
cartilage at 18 months over the anterior half of both the medial femoral condyle and medial 
tibial plateau. 
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Fig. 32. (A) Sagittal MRI (STIR) over the medial compartment. White arrow over the 
anterior half of the medial tibial plateau showing evidence of chondrogenesis. Red arrow 
over the posterior half of the medial tibial plateau whereby the “Inkwell” technique was 
applied showed minimal chondrogenesis. (B) Coronal MRI (STIR) over the posterior half 
of the medial tibial plateau. White arrow over the medial femoral condyle showing 
chondrogenesis. Red arrow over the medial tibial plateau showed minimal 
chondrogenesis.  
Histology from the chondral core biopsy of the medial femoral condyle and anterior half of 
the medial tibial plateau confirmed the regeneration of hyaline cartilage (Fig 33).This case 
further supports the theory of ideal drilling with abrasion chondroplasty in uncontained 
lesions (Figs 26 and 28). With ideally placed drill holes and abrasion chondroplasty, there 
will be a larger volume of blood-clot scaffold for the injected PBPC and HA to form closely 
integrated individual tufts of cartilage. These closely seeded tufts arising from the 
subchondral bone will eventually coalesce to cover the bony defect. Chondrogenesis with 
maturation will result in increasing thickness of the regenerated cartilage covering the entire 
defect. 
In the absence of subchondral drilling over the posterior half of the medial tibial plateau, the 
“Inkwell” procedure only produces minimal surface coverage as compared to the anterior 
half of the tibial plateau. 
Case 7: A 45-year-old woman underwent right knee arthroscopic lateral patellar release and 
ideally placed subchondral drilling to the lateral patella facet and lateral trochlear (Fig 34). 
Beginning one week after surgery,  5 weekly intraarticular injections of HA were given to 
the operated knee. No PBPC was added to the HA during the intraarticular injections. 
Radiographs (Fig 35) show improvement of the lateral patellofemoral articulation. In the 
absence of PBPC in combination with HA, the repair process was only patchy in some areas 
and the regenerated tissue was found to be of fibrocartilage in nature (Fig 34 and 36). 
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Fig. 33. Case 6 – Histological features showing hyaline cartilage regeneration from the 
medial femoral condyle and medial tibial plateau biopsies. 
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Fig. 34. A 45-year-old woman with intraoperative (Intra-op) and second-look arthroscopy at 
19 months. Despite ideal drilling but without postoperative intraarticular injections of PBPC 






Fig. 35. (A) Preoperative (Pre-op) merchant view showing lateral patellar maltracking with 
absence of the lateral patellofemoral articulation. (B) XR at 18 months showed improvement 
of the lateral patellofemoral articulation. 
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Fig. 36. Case 7 - Histological features showing fibrocartilage repair from the lateral patella 
facet and lateral trochlear biopsies. 
The importance of adjuvant PBPC in combination with HA is well emphasised in this case. 
In the absence of PBPC, even though ideal subchondral drilling was performed, 
intraarticular injections of HA alone is ineffective in complete coverage of the bony drill 
holes and initiate satisfactory articular cartilage repair. 
Case 8: A 49-year-old man underwent high tibial osteotomy with Tomofix plate fixation, 
lateral patellar release and ideal subchondral drilling into the tri-compartmental chondral 
defects. PBPC in combination with HA were injected intraarticularly into the operated knee 
1 week after surgery for a total of five weeks. Postoperative radiographs at 19 months 
showed reappearance of the lateral patella articulation and improvement of the medial 
compartment (Fig 37). 
Second-look arthroscopy with chondral core biopsy from the lateral trochlear (Fig 38), 
medial and lateral femoral condyles (Fig 39) showed evidence of hyaline cartilage 
regeneration (Fig 40). In contrast to case 7 which presented with only chondral defects over 
the lateral patellofemoral joint, case 8 showed satisfactory chondrogenesis with hyaline 
cartilage regeneration in all 3 compartments. With the addition of postoperative 
intraarticular injections of PBPC and HA following subchondral drilling, it is possible to 
address multiple chondral lesions in addition to the difficult to treat “Kissing” lesions. 
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Fig. 37. A 49-year-old man underwent high tibial osteotomy, lateral patellar release and tri-




Fig. 38. Second-look at 19 months showed satisfactory coverage of the bony defects by the 
regenerated tissue. 
Intraoperative 
Preoperative Postoperative 19 months
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Fig. 40.  Case 8 - Histological features showing hyaline cartilage regeneration from the LT, 
LFC & MFC biopsies. 
Intraoperative 
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7.4.8 The importance of PBPC + HA as adjuvant therapy following ideal subchondral 
drilling 
Case 6 emphasizes on the importance of the improved technique of ideal drilling in an 
uncontained lesion. Cases 7 & 8 illustrates the importance of postoperative intraarticular 
injections of PBPC + HA. 
Possible reasons as to why the microfracture technique has not been successful in achieving 
consistent coverage with hyaline cartilage can be explained by what is seen on second-look 
arthroscopy in cases 6, 7 and 8. Firstly, microfractures are usually placed 3 to 5 mm apart and 
do not penetrate much deeper than the calcified cartilage layer. Microfractures placed more 
superficially and further apart as compared to ideal subchondral drilling explains one of the 
possible reasons why the microfracture technique is inconsistent in producing satisfactory 
articular cartilage repair. Secondly, like the animal model in Fig 9, without postoperative 
adjunct therapy with PBPC + HA, the regenerated tissue will always be of inferior quality.  
7.4.9 Role of weight-bearing 
Our biopsy specimens from cases with subchondral drilling followed by postoperative 
intraarticular injections of PBPC in combination with HA showed histologic features of 
hyaline cartilage with anti–collagen type I stain (used to highlight collagen type I), anti– 
collagen type II stain (used to highlight collagen type II), and Safranin-O stain (used to 
highlight proteoglycans), with the exception of one histologic sample showing mixed 
cartilage. This biopsy specimen was from an area of abrasion notchplasty, which 
represented a non–weight-bearing region. Comparison of biopsy specimens from this non– 
weight-bearing area to those from a weight-bearing area in the same patient has led us to 
theorize that early partial-weight-bearing is essential for the regeneration and alignment of 
collagen type II (Fig 18). 
7.4.10 Articular cartilage imaging of the knee 
Articular cartilage is visible on most standard MRI sequences as a band of intermediate to 
high signal covering the articular aspect of the bone. Non-injured articular cartilage 
normally shows a continuous subchondral dark line (low-signal) below the articular 
cartilage. This dark line likely represents the layer of calcified cartilage and the associated 
subchondral bone plate. It may be accentuated by chemical shift artifact (of water and fat 
molecules in the same voxel canceling their respective signals thereby resulting in signal 
loss). Fig 41 illustrates the articular cartilage and subchondral bone on a sagittal PD image. 
Evaluating postoperative MRIs, we assessed the restoration of the dark line as evidence of 
calcified cartilage with subchondral bone healing and fill of the defect as indicative of 
cartilage regeneration. 
Our current imaging preference for assessing chondral lesions of the knee joint utilize 2D 
PD and PDFS sequences using a high field (1.5T) extremity MRI (GE Medical Systems) – Fig 
42. This has the benefits of improved signal to noise and higher resolution. Fig 43 showing 
examples of chondral lesions seen following MRI scan with arthroscopic correlation (Fig 44). 
Our earlier cartilage images were obtained by an open MRI system operating at 0.35T 
(Magnetom C!, Siemens Medical Solutions, Erlangen, Germany) using an extremity receive 
coil. 
MRI scans were utilized preoperatively as part of the diagnostic work up and 
postoperatively to monitor healing of the chondral defects. We performed MRI scans at 
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shorter intervals for our first 10 patients. Scans were performed on the first postoperative 
day as a baseline to document the chondral defect after debridement and subchondral 
drilling. Serial studies were then collected in the postoperative period (at 6, 12, 18, 24 
months and beyond) to evaluate the filling of the defect by regenerated cartilage and 
changes in the subchondral bone. 
 
 
Fig. 41. Articular cartilage as depicted by sagittal PD image at the tibial plateau. Black arrow 
showing the surface of the tibial plateau articular cartilage and red arrow showing the 
“Black line” that separates the articular cartilage from the subchondral bone. This layer 
correlates with the tidemark / calcified cartilage / subchondral bone plate layers. 
 
 
Fig. 42. A patient with her right knee in a high field extremity (1.5T) MRI (GE Medical 
Systems). 
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Fig. 43. Images of chondral lesions demonstrated by extremity high field MRI at 1.5T. (A) 
Chondral flap tear of the medial femoral condyle (white arrow) with red arrow showing a 
delaminated chondral lesion over the lateral femoral condyle (PDFS). (B) The corresponding 










Fig. 44. Corresponding arthroscopic view of the lesions from the medial femoral condyle 
(MFC) and lateral femoral condyle (LFC) as in Fig 43. 
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MRI scans performed on the first postoperative day showed the chondral defects as well 
delineated from surrounding healthy cartilage. The chondral defects were bare or 
partially filled in with blood clot. Drill tracts and subchondral marrow edema were clearly 
observed (Figures 45 to 47). Subchondral bone is disrupted, i.e. there is loss of the 
continuity of the subchondral black line. Over the course of two years, filling-in of the 
chondral defects by material of similar or same signal as articular cartilage was observed. 
Re-establishment of subchondral black line paralleled the progressive resolution of 
marrow edema.  
Serial MRI scans of our first patient undergoing this treatment are presented in Figure 45. 
After full debridement and drilling, the chondral defect is well visualized as a bare area 
partially filled by clot (Figure 45A). The low signal subchondral bone is disrupted and low 
signal drill tracts are visualized within the subchondral marrow edema. The disruption of 
the subchondral dark line represents a conduit through the calcified cartilage layer. Serial 
scans showed progressive filling of chondral defects by material of similar appearance as 
articular cartilage, resolution of marrow edema and reappearance of the continuous 
subchondral dark line (Figure 45B). At one to two years, the calcified cartilage, as depicted 
by the low signal band, becomes almost as thick at the site of drilling as in the surrounding 




Fig. 45. Serial MRI evaluation (STIR images at 0.35T). Postoperative (Post-op): note the 
disruption of the subchondral dark line (red arrow). (B) 2 months: partial resolution of 
marrow edema and reappearance of the continuous subchondral dark line (red arrow). (C) 
10 months: almost complete resolution of marrow edema and filling of defect. (D) 20 
months: complete healing of defect and re-establishment of subchondral dark line 
representing healing of the calcified cartilage layer. 
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Fig. 46. A 40-year-old woman with patellar dislocation (STIR images at 0.35T). (A) 
Preoperative MRI with evidence of a delaminating articular cartilage injury and medial 
patellar femoral ligament (MPFL) injury. The injury was treated with arthroscopic lateral 
release, subchondral drilling and repair of the MPFL. (B) Postoperative (Post-op) MRI 
following arthroscopic lateral patellar release (red arrow) and subchondral drilling showing 
interruption of the low signal subchondral calcified cartilage (white arrows). (C) At one year 
following surgery, MRI revealed a healed lateral retinaculum (red arrow), re-establishment 
of the subchondral calcified cartilage (white arrows) and evidence of articular cartilage 
regeneration at the lateral patella facet.   
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Fig. 47. Sagittal PD MRI (0.35T) of patient in Figure 46. (A) Postoperative (Post-op) MRI: 
chondral lesions at the lateral patella and lateral femoral chondyle (arrows). Note the 
disruption to the continous low signal calcified cartilage layer at both sites. (B) MRI at one 
year after surgery showing the re-establishment of the subchondral calcified cartilage layer 
(long arrows) together with articular cartilage regeneration (short arrows).  
The re-establishment of the calcified cartilage layer and healing of the subchondral bone are 
important MRI features of articular cartilage regeneration in our series. This is accompanied 
by filling of the chondral defect. Following arthroscopic subchondral drilling, MRI images 
revealed extensive marrow edema and interruption of the calcified cartilage layer together 
with the underlying subchondral bone. This is shown as disruption of the low signal 
subchondral dark line. As the injected PBPC seed the blood clot scaffold in the presence of 
HA, chondrogenesis is initiated with the formation of chondrocytes which then occupy the 
drill holes. This process is gradually replaced by bone resulting in subchondral bone repair. 
Gradual resolution of marrow edema is observed. The subchondral dark line progressively 
re-appears on MRI scans indicating the re-establishment of the calcified cartilage layer and 
healing of the subchondral bone (Figures 45 to 47). This evidence is provided from the 
histology shown on Figures 20 and 21. Depending on whether the lesion is a contained or 
uncontained lesion, chondrogenesis follows the gradual re-appearance of this subchondral 
dark line on serial MRI scans (Figures 24 and 26).  
7.4.11 Phase I study clinical outcomes 
Since starting clinical trials in 2007, 223 cartilage regeneration cases have been performed 
on 205 patients. Cases were varied including 38 cases involving isolated cartilage lesions, 
92 cases involving multiple cartilage lesions, 54 cases involving patellofemoral cartilage 
lesions, 7 cases involving concomitant lower limb realignment procedures, and 32 cases 
involving ligament reconstruction. When evaluating two-year clinical outcomes, 24 
months has passed for 155 of these 223 cases. Within this group, 52 cases have 
preoperative, 12-month, and 24-month IKDC values available for clinical outcome 
evaluation. This group had a preoperative IKDC average of 50.5, a 12-month IKDC 
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average of 70, and a 24-month IKDC average of 70.  30 patients had 30-month data 

























Fig. 48. International Knee Documentation Committee (IKDC) outcomes. 
Our IKDC results illustrated a significant increase similar to studies documenting overall 
outcomes in the literature with marrow stimulation and chondrocyte implantation. 
Historically, microfracture has shown a peak functional outcome at 24 months (Blevins et al, 
1998; Peterson et al, 2000; Steadman et al, 2003; Gobbi et al, 2005, Mithoefer et al, 2005; 
Knutsen et al, 2007). Two studies have illustrated a decline after the first 18 to 24 months 
with microfracture, including Mithoefer et al (2005) documenting 69% of their patients 
reporting lower IKDC scores after 24 months. Conversely, two outcome studies have found 
sustained improvement at the 24-month time interval (Steadman et al, 2003; Kneutsen et al, 
2004). In comparison of these four studies, the average age of the study groups documenting 
decline was 39.5 years and 41 years. In contrast, the average age of the studies documenting 
sustained improvement was 30.4 years and 31.1 years (Steadman et al, 2003; Mithoefer et al, 
2005; Kruez et al, 2006; Knutsen et al, 2004). In a group with an average age of  47.1 years, 
our IKDC scores showed sustained improvement at 24 months with 30 cases documenting 
continued improvement at 30 months. 
Comparing microfracture and chondrocyte implantation, decisive superiority has not been 
established. Two randomized studies have sought to directly compare outcomes with 
differing results. Saris et al. (2009) found significantly better outcomes with ACI at 36 
months. They found a continued increase in Knee Injury and Osteoarthritis Outcome Scores 
(KOOS) from 6 to 36 months with ACI and a plateau in scores at 18 months with 
microfracture (Saris et al, 2009). However, Knutsen et al. found no significant clinical or 
radiographic difference between microfracture and ACI at 60 months utilizing four clinical 
outcome scoring systems and 2 radiologic outcome systems (Knutsen et al,2007). Zeifang et 
al. (2010) in comparison of conventional methods of ACI with refined methods of ACI for 
treatment of femoral chondral lesions found an increase from a baseline IKDC (51.1) by 21 
points and 25 points respectively. This series had an average age of 29.3 years (Zeifang et al, 
2010). At 24 months, this rise declined slightly in the conventional method to 19 points 
www.intechopen.com
 Articular Cartilage Regeneration with Stem Cells 
 
173 
above baseline and remained stable in the refined method at 25 points above baseline 
(Zeifang et al, 2010).  This compares to our rise above a baseline IKDC of 50.5 by 20 points at 
12 months, 20 points at 24 months, and 21 points at 30 months (Fig 48). Of note, our patient 
group has a mean age of 47.1 years and included patients with multiple chondral lesions, 
while Zeifang et al. (2010) evaluated isolated defects of the femoral condyle.  
Our clinical results indicate that the regenerated tissue is resilient and coincide with 
histological results suggesting that this technique produces hyaline cartilage. However, 
evaluating phase I data has weaknesses. As this portion of the clinical trial has included 
evolution in technique and cell processing, there is some inherent variation.  Additionally, 
IKDC collection was inconsistent in the initial phases. Also, when attempting to evaluate 
this early data, there is no control group available for comparison.  Currently a randomized 
controlled trial is underway under the direction of the first author. 
7.4.12 Complications 
Specific complications are mild bone pain associated with Neupogen injections, and 
discomfort of PBSC harvesting and localized pain following intraarticular injections with 
PBPC and HA. One male patient in his mid-forties had a previous infection from Anterior 
Cruciate Ligament (ACL) surgery, multiple microfractures and subsequent ACL revision 
surgery with postoperative PBPC and HA. He had recurrence of intercondylar osteophytes 
and reactive arthritis and eventually chose a total knee replacement. Three other patients 
had secondary procedure for persistent osteophytes and treatment for further areas of 
chondral degeneration. 
It is evident that with adjuvant PBPC and HA therapy, chondrogenesis is possible with 
hyaline cartilage, but a small proportion of patients may return for further treatment 
because of newly diagnosed areas of chondral degeneration in the treated knee. 
7.5 Current control randomized trial 
A randomized controlled trial comparing a group with PBPC and HA injections with a 
group with HA injection alone following arthroscopic subchondral drilling is currently 
under way, being supervised by the first author. The early results seem to support the 
benefit of adjuvant postoperative intraarticular injections of PBPC in combination with 
HA.  
7.6 Summary of theory 
Our theory is that providing a high percentage of immature multipotent progenitor cells 
into the right environment allows these cells to populate areas of subchondral drilling and 
regenerate hyaline cartilage. Our histologic findings of chondrocytes below the calcified 
cartilage layer at a subchondral drill hole (Figs 20 and 21) and the porcine model (Lee et al, 
2007) illustrating mesenchymal stem cells at the base of newly formed cartilage support the 
idea that injected progenitor cells are attracted to the site of marrow injury, proliferate into 
chondrocytes, and regenerate hyaline cartilage from the subchondral base. We theorize that 
the addition of matrix substance, in the form of HA and passive stimulating kinetic 
movement of the involved joint (continuous passive motion), provides chemical and cellular 
signals for regeneration. Partial to full weight-bearing in the early phase of rehabilitation 
provides the essential environment to assist in the remodelling of the collagen fibrils to align 
along the axis of weight transmission. 
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It is evident that for ideal chondrogenesis with hyaline cartilage in contained or uncontained 
lesions, the correct surgical technique with attention to detail, a postoperative adjuvant 
therapy with a high percentage of viable PBPC in combination with HA, and the importance 
of a postoperative rehabilitation program are important. Failure to adhere to these three 
important basic principles will result in inferior repair tissue which will inevitably 
deteriorate with time. 
Articular hyaline cartilage regeneration is possible with arthroscopic subchondral drilling 
followed by postoperative intraarticular injections of autologous PBPC in combination 
with HA. 
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